HGH Injection Pen

Overview

The HGH Injection Pen is a pre-filled, multi-dose injection pen device containing recombinant human growth hormone (somatropin). Designed for precision and convenience in research dosing protocols, this pen delivery system eliminates the need for manual reconstitution and offers consistent, accurate dosing across multiple administrations.

Recombinant human growth hormone (rhGH) is a 191-amino acid protein identical to endogenous pituitary-derived growth hormone. Produced using recombinant DNA technology, rhGH provides a reliable and pure research tool for studying the somatotropic axis and GH-dependent physiological processes.

The pen device format offers several advantages for research applications, including reduced preparation time, minimized contamination risk, improved dosing accuracy, and enhanced stability of the formulated product compared to traditional vial-and-syringe delivery.

Chemical Profile

Mechanism of Action

Recombinant human growth hormone acts through binding to the growth hormone receptor (GHR), a type I cytokine receptor expressed on hepatocytes, adipocytes, chondrocytes, muscle cells, and immune cells. GH binding induces receptor dimerization and activation of the JAK2-STAT5 signaling pathway.

In the liver, GH-JAK2-STAT5 activation drives the transcription of IGF-1, the primary mediator of GH's growth-promoting effects. The GH-IGF-1 axis regulates linear growth, protein synthesis, and cell proliferation. GH also has direct (IGF-1-independent) effects on lipolysis, glucose metabolism, and immune function.

The pen delivery format ensures consistent subcutaneous deposition and absorption kinetics, producing reproducible pharmacokinetic profiles suitable for research protocols requiring standardized dosing.

Research Applications

• Somatotropin biology and GH receptor signaling
• IGF-1 axis modulation and metabolic effects
• Growth and development research
• Body composition and protein metabolism
• Pen device delivery optimization
• Pharmacokinetic consistency studies

Handling & Reconstitution

1. 1Remove the pen from refrigerated storage and allow it to reach room temperature (15-25 minutes).
2. 2Attach a new sterile pen needle according to device instructions.
3. 3Prime the pen by dialing and expelling a small test dose.
4. 4Dial the desired research dose.
5. 5Administer subcutaneously per research protocol.
6. 6Remove and safely dispose of the needle after each use.
7. 7Return the pen to refrigerated storage (2°C – 8°C) immediately after use.